New cancer clinical trial: Anlotinib Combined With Pemetrexed And Carboplatin as the First-line Treatment in Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer

Published on: January 01, 2019
Condition:   Non-squamous Cell Non-Small Cell Lung Cancer
Intervention:   Drug: Anlotinib Combined With Pemetrexed And Carboplatin
Sponsors:   Henan Cancer Hospital;   Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Recruiting
http://bit.ly/2s3SXeg Anlotinib Combined With Pemetrexed And Carboplatin as the First-line Treatment in Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer